With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...
Jabil Inc., a provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International ...
Jabil's diversification in end markets, particularly Auto & Transportation and Healthcare & Packaging, is driving revenue ...
An investor group led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc have sold their equity stake in Pharmaceutics International, Inc, a Hunt Valley, ...
Hosted on MSN1mon
Jabil Inc. (JBL) Drives Growth with AI Integration, Strategic Partnerships, and Strong Q1 Performance; Price Target Raised to $165 by BofA AnalystIn this article, we are going to take a look at where Jabil Inc. (NYSE:JBL) stands against the other AI stocks. Artificial intelligence has become a dominant force in the stock market, driving the ...
Jabil (JBL – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Ruplu Bhattacharya from Bank of America Securities reiterated a Buy rating on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback